Sabra Health Care REIT Inc. Common Stock (SBRA)
Stock · NASDAQ · Real Estate
$19.35as of 10/16/2026
Price chart
Active signals
SBRA Signal Track Record
How signals performed across all stocks →What SBRA's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakout | 28 | +1.1% | 54% | July 21, 2026 |
| Volume Spike | 25 | +4.0% | 76% | September 18, 2026 |
| Bollinger Band Breakdown | 19 | +7.8% | 74% | September 16, 2026 |
| 200-Day Moving Average TouchActive now | 17 | +5.7% | 76% | September 18, 2026 |
| Any 20-session window (baseline) | +1.5% | 60% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SBRA
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
- Sector
- Real Estate
- Industry
- Real Estate Investment Trusts
- Employees
- 58
- Website
- sabrahealth.com/
Fundamentals
- 1-day range
- $19.19$19.54
- Market cap
- $5.34B
- P/E (trailing)
- 75.71
- P/E (forward)
- 23.88
- EPS (trailing)
- $0.26
- Dividend yield
- 8.27%
- Beta
- 0.65
- Avg. volume
- 2.58M
- Ex-dividend date
- August 14, 2026
- Dividend pay date
- August 31, 2026
How Sabra Health Care REIT Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 12, 2026 · via SEC EDGAR / Finnhub
Forecasts
14 analyst ratings
Sabra Health Care REIT Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- SBRASabra Health Care REIT Inc. Common Stock$19.34▲ 0.26%Market cap $5.34BP/E 75.71$17.17$22.77
- KRGKite Realty Group Trust Common Stock$24.61▲ 0.37%Market cap $5.35BP/E 14.55$21.4$29.92
- OUTOUTFRONT Media Inc. Common Stock$30.38▲ 1.44%Market cap $5.48BP/E 21.36$16.97$34.96
- RITMRithm Capital Corp. Common Stock$8.66▼ 0.57%Market cap $5.55BP/E 10.47$8.31$12.15
- CUZCousins Properties Incorporated Common Stock$27.64▲ 0.11%Market cap $4.91BP/E 707.08$21.03$32.95
- STWDSTARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.$12.46▼ 1.19%Market cap $5.91BP/E 20.53$12.27$19.06
- EPREPR Properties Common Stock$55.71▲ 1.02%Market cap $4.70BP/E 16.07$48.11$64.97
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SBRA Sabra Health Care REIT Inc. Common Stock | $5.34B | 75.71 | $19.34 | ▲ 0.26% | $17.17$22.77 |
| KRG Kite Realty Group Trust Common Stock | $5.35B | 14.55 | $24.61 | ▲ 0.37% | $21.4$29.92 |
| OUT OUTFRONT Media Inc. Common Stock | $5.48B | 21.36 | $30.38 | ▲ 1.44% | $16.97$34.96 |
| RITM Rithm Capital Corp. Common Stock | $5.55B | 10.47 | $8.66 | ▼ 0.57% | $8.31$12.15 |
| CUZ Cousins Properties Incorporated Common Stock | $4.91B | 707.08 | $27.64 | ▲ 0.11% | $21.03$32.95 |
| STWD STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc. | $5.91B | 20.53 | $12.46 | ▼ 1.19% | $12.27$19.06 |
| EPR EPR Properties Common Stock | $4.70B | 16.07 | $55.71 | ▲ 1.02% | $48.11$64.97 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- UBS Maintains Neutral on Sabra Health Care REIT, Lowers Price Target to $20benzinga · 10/13/2026
- Omega Healthcare: Attractive For The Near 6% Yield, But Don't Expect Meaningful Upside (Rating Downgrade)SeekingAlpha · 9/26/2026
- Sabra Health Care: This Silver Tsunami Opportunity Is Just Getting StartedSeekingAlpha · 9/15/2026
- Sabra Health Care REIT: This 5.85% Healthcare REIT Is UndervaluedSeekingAlpha · 9/15/2026
Insider Activity
Insider Actions →- Richard K. Matros · September 8, 2026 · Sale200.0K @ $20.83
- Darrin Smith · August 31, 2026 · Grant495
- Jessica Flores · August 31, 2026 · Grant382
- Catherine Cusack · August 31, 2026 · Grant791
- Michael Lourenco Costa · August 31, 2026 · Grant4.2K
- Ann Kono · August 31, 2026 · Grant791
- Lynne S. Katzmann · August 31, 2026 · Grant791
- Jeffrey A. Malehorn · August 31, 2026 · Grant791
- Craig A. Barbarosh · August 31, 2026 · Grant791
- Richard K. Matros · August 31, 2026 · Grant13.9K
- Michael J. Foster · August 31, 2026 · Grant791
- Catherine Cusack · June 17, 2026 · Grant8.3K
- Ann Kono · June 17, 2026 · Grant8.3K
- Lynne S. Katzmann · June 17, 2026 · Grant8.3K
- Jeffrey A. Malehorn · June 17, 2026 · Grant8.3K
Institutional Ownership
March 31, 2026
- Total shares held
- 224.62M
- Total value held
- $4.19B
- Institutional holders
- 448
- Unknown39.10M
- Unknown25.05M
- Unknown12.10M
- Unknown11.23M
- Unknown7.45M
- Unknown6.67M
- Unknown5.41M
- Unknown4.77M
- Unknown3.88M
- Unknown3.82M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Sabra Health Care REIT analysts lower price targets
UBS kept a neutral rating on Sabra Health Care REIT but reduced its price target to $20. Barclays also maintained an equal‑weight stance while cutting its target to $21. Both revisions suggest a more modest outlook for the REIT. The new targets sit near the stock’s recent support level around $19.70.
Sabra Health Care REIT analysts lower price targets. UBS kept a neutral rating on Sabra Health Care REIT but reduced its price target to $20. Barclays also maintained an equal‑weight stance while cutting its target to $21. Both revisions suggest a more modest outlook for the REIT. The new targets sit near the stock’s recent support level around $19.70.